A Phase 1b clinical trial investigating tucatinib combined with ado-trastuzumab emtansine in advanced ERBB2/HER2-positive metastatic breast cancer has yielded encouraging results.
Browsing: Taxonomy > Clinical trials
In this piece, discover key talks and highlights from the World Congress on Gastrointestinal Cancer 2018.
NICE have approved Alecensa for use on the NHS, following positive data from a Phase II trial, including a reduced risk of brain metastasis.
The Phase III IMpower133 study has met its overall survival and progression-free survival co-primary endpoints.
Clinical data demonstrates improvement in metastatic gastric cancer patient overall survival in comparison with the placebo.
Adjuvant FOLFIRINOX chemotherapy has become the standard of care for pancrearic cancer patients following the release of data from the Phase III PRODIGE 24/CCTG PA.6 trial.
In a medical breakthrough, a new approach to immunotherapy has led to complete regression of breast cancer in a patient unresponsive to all other treatments.
Researchers have demonstrated that taking a high dose of esomeprazole (Nexium®) along with a low dose aspirin, for at least 7 years, can reduce the risk of develop a high-grade dyslplasia or esophageal cancer.
The PRODIGE 7 randomized study has demonstrated that for advanced colorectal cancer patients, hyperthermic intra-peritoneal chemotherapy delivered to the abdomen during surgery, may not be necessary.